0001415889-23-009989.txt : 20230620 0001415889-23-009989.hdr.sgml : 20230620 20230620140131 ACCESSION NUMBER: 0001415889-23-009989 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas John C CENTRAL INDEX KEY: 0001424620 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39811 FILM NUMBER: 231024459 MAIL ADDRESS: STREET 1: 8601 SIX FORKS ROAD, SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Virios Therapeutics, Inc. CENTRAL INDEX KEY: 0001818844 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 854314201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 8666208655 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Virios Therapeutics, LLC DATE OF NAME CHANGE: 20200721 4 1 form4-06202023_060625.xml X0407 4 2023-06-15 0001818844 Virios Therapeutics, Inc. VIRI 0001424620 Thomas John C C/O VIRIOS THERAPEUTICS, INC. 44 MILTON AVENUE ALPHARETTA GA 30009 true false false false 0 Stock Option (right to buy) 1.85 2023-06-15 4 A 0 5250 0 A 2033-06-15 Common Stock 5250 5250 D The stock option will vest 100% on June 15, 2024, one year following the grant date. /s/ Greg Duncan, Attorney-in-Fact 2023-06-20